RESEARCH PAPER
Estimate Hyoscine Butylbromide and Mefenamic Acid by RP-HPLC Method Development and Accelerated Stability Study in Pure and Combine Dosage Form
 
More details
Hide details
1
Department of Quality Assurance, Sardar Patel College of Pharmacy, Gujarat Technological University, Gujarat, INDIA
2
Department of Pharmacognosy, Sardar Patel College of Pharmacy, Gujarat Technological University, Gujarat, INDIA
3
Department of Pharmacology, Sardar Patel College of Pharmacy, Gujarat Technological University, Gujarat, INDIA
Online publish date: 2018-05-11
Publish date: 2018-05-11
 
Eurasian J Anal Chem 2018;13(4):em35
KEYWORDS:
TOPICS:
ABSTRACT:
The aim of the present study was to develop and validate stability indicating HPLC method for simultaneous estimation of Hyoscoine butyl bromide (HBB) and Mefenamic acid (MEF). HPLC method for simultaneous analysis of both drugs was developed and validated according to ICH guideline. Efficient chromatographic separation was achieved on ODS column C18 (250 mm × 4.6 mm, 5 μm) using the optimized mobile phase. Stability indicating assay method was carried out by different stress degradation conditions. In HPLC method, the Retention time for HBB and MEF was 3.21 and 5.07 min using optimized mobile phase potassium dihydrogen phosphate buffer (pH 5.0) and methanol (60:40 % v/v) with a flow rate of 1 ml/min. The multiple wavelength UV detector was set at a 237 nm for measurement of all compound. Quantification based on measuring the peak areas. The degradation of HBB, MEF and Formulation was shown to be highest in alkaline condition. Linearity was observed in concentration range of 1- 3μg/ml and 12.5-37.5 μg/ml for HBB and MEF respectively. All validation parameters were within the acceptable range. Moreover, the % RSD for repeatability, inter and intraday precision was found to be within the range, which reveals that the method is precise. Accuracy study of the drug in marketed preparation also report in the limit. Assay of the dosage form finalized the applicability of this method for estimation of Hyoscine Butylbromide and Mefenamic Acid tablet dosage form.
 
REFERENCES (25):
1. Tripathi KD. Essential of Medical Pharmacology, New Delhi: Jaypee brothers medical publishers (p) Ltd. 2008.
2. “Drug profile for Hyoscine butylbromide”, Sep-2016. Available at: http://www.chemspider.com/Chem... structure.16736107.
3. Brunton L, Chabner, BA, Knollman B. Goodman & Gilman’s the pharmacological basis of therapeutics, Mcgraw-Hill Medical. NK. 2003.
4. “Drug profile for Mefenamic Acid”, Sep-2016, Available at: http://www.chemspider.com/Chem... structure.3904.
5. Yonis, MS, Al-Saidi, KH. Simultaneous Determination of Paracetamol and Hoscine Butylbromide in Binary Mixture using Derrivative Spectrophotometry by Journal of Al-Nahrain University. 2016;19(1):56-68.
6. Ali N, Gamal M, Abdelkawy M. Determination of Hyoscine Butylebromide and Paracetamol mixture by zero order and first derivative ratio spectrophotometric method by Annalen der Chemischen Forschung. 2014;2(1):9-19.
7. Ali N, Gamal M, Abdelkawy M. Simultaneous Determination of Dipyrone and Hyoscine Butylbromide in Binary Mixture by RP-TLC Spectrodensitometric method by International Journal of Chemical and Analytical Science. 2012;3(10):1578-1582.
8. Ali N, Gamal M, Abdelkawy M. Simultaneous Estimation of Hyoscine Butyle Bromide and Paracetamol in their Binary Mixture by RP-HPLC by Arabian Journal of chemistry. 2014; 1-7.
9. Dhabarde DM, Hatwar H, Kamble M, Ingole A. Simultaneous Estimation of Hyoscine Butyle Bromide and Paracetamol in their combined Dosage form by RP-HPLC by International journal of advance in pharma Research. 2014;5(3):169-175.
10. Saharty YS, Metwally FS, Refaat M. Simutaneous Determination of Hyoscine Butylbromide and Ketoprofen in pharmaceutical preparation by spectrophotometric and HPLC Method by International journal of analysis. 2007;90(1):102-112.
11. Ali N, Gamal M, Abdelkawy M. LC-MS As a stability indicating method for analysis of Hyoscine N-Butylbromide under Stress degradation Condition with identification of Degradation product by Pharmaceutica analytica acta. 2013;7:1-5.
12. Sharma MC. Simultaneous Estimation and Validation of Mefenamic acid and Drotaverine HCl in Tablet dosage form by World Applied Sciences Journal. 2013;28(9):1181-1187.
13. Prajapati D, Raj H. Simultaneous Estimation of Mefenamic acid and Dicyclomine by Spectrophotometric method by International Journal of Pharmaceutical science and Research. 2012;3(10):3766-3776.
14. Natesan S, Thanasekaran D, Krishnaswami V, Ponnusamy C. Improved RP-HPLC Method for Simultaneous Estimation of Mefenamic acid and Tranexamic acid in Tablet Dosage form by Pharmaceutica analytica acta. 2011;2(1):1-6.
15. Shrikrishna B, Sugandha M, Nisharani R. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Mefenamic acid and Dicyclomine by Journal of pharmaceutical research. 2014;13(1):16-19.
16. Prajapati D, Raj H. Simultaneous Estimation of Mefenamic acid and Dicyclomine by RP HPLC Method by International. Journal of Pharmacy and Bio science. 2012;3(3):611-625.
17. Premanand DC, Sethilkumar KL, Saravan M, Thitumurthy R. Simultaneous Estimation of Mefenamic acid and Drotaverine HCl in Combined Dosage form by RP-HPLC Method by Der Pharma chemical. 2010;2(5):170-177.
18. Rathinam S, Lakshmi KS. HPTLC Method for Simultaneous Estimation of Mefenamic acid and Camylofin Di HCl in Tablet Dosage form by International Journal of pharmacy and pharmaceutical Science. 2014;6(1):585-589.
19. Patil PA, Umarkar AR, Bari MM, Barhate SD. Stability Indicating RP-HPLC Method for Determination of Drotaverine HCL and Mefenamic Acid in Pure and Pharmaceutical Formulation. American Journal of Advanced Drug Delivery. 2015;3(2):110-122.
20. Dhumal BR, Bhusari KP, Tajne MR, Ghante MH, Jain NS. Stability indicating method for the determination of Mefenamic acid in pharmaceutical formulation by HPLC by Journal of Applied Pharmaceutical Science. 2014;4(12):60-64.
21. Indian Pharmacopoeia. The Indian Pharmacopoeia Commission. Ghaziabad: Govt. of India Ministry of Health and Family Welfare, (II), 2014;2:1641-1642.
22. British pharmacopoeia. vol I-II, Monograph: Medicinal and pharmaceutical science: Mefenamic acid. 2013;1-4.
23. United States Pharmacopoeia & National Formulary. The United states pharmacopoeia convention INC. USA: 2560, 2007.
24. ICH, Q2(R1) Validation of Analytical Procedures. Methodology, International Conference on Harmonization. IFPMA. Geneva; 1996.
25. ICH, Q1A(R2), Stability Testing of New Drug Substances and Products. International conference on Harmonization, IFPMA, Geneva, Switzerland; 2003.
eISSN:1306-3057